Sign up to save your podcasts
Or
Share FDA Approved Therapy for SOD1 Associated ALS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Approved Therapy for SOD1 Associated ALS
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
View all episodes
By American Academy of Neurology
4.7
284284 ratings
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
More shows like Neurology® Podcast
View all
NEJM This Week
320 Listeners
JAMA Clinical Reviews
496 Listeners
Practical Neurology Podcast
50 Listeners
Mayo Clinic Talks
294 Listeners
The Curbsiders Internal Medicine Podcast
3,349 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,147 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
193 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
135 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Neurology Exam Prep Podcast
189 Listeners
The Curious Clinicians
373 Listeners
Continuum Audio
82 Listeners